サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1782021

低侵襲生検技術市場：提供製品別、技術別、循環バイオマーカー別、用途別、エンドユーザー別、国別、地域別：世界産業分析、市場規模、市場シェア、2025年～2032年予測

Minimally Invasive Biopsy Techniques Market, By Product Offered, By Technique, By Circulating Biomarker, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 393 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
低侵襲生検技術市場：提供製品別、技術別、循環バイオマーカー別、用途別、エンドユーザー別、国別、地域別：世界産業分析、市場規模、市場シェア、2025年～2032年予測
出版日: 2025年07月21日
発行: AnalystView Market Insights
ページ情報: 英文 393 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

低侵襲生検技術の市場規模は2024年に131億4,612万米ドルとなり、2025年から2032年にかけてCAGR 10.5％で拡大

低侵襲生検技術市場-市場力学

世界のがん罹患率の増加と精密診断の重要性の高まりが市場成長を促進すると予測されます。

がんの罹患率が世界的に上昇を続ける中、早期かつ精密で、侵襲性の低い診断方法が急務となっています。細針吸引、コア針生検、リキッドバイオプシーを含む低侵襲生検技術は、従来の外科的アプローチと比較して、回復時間の短縮、患者の不快感の軽減、合併症の発生率の低下をもたらします。世界保健機関（WHO）は、新たながん患者数は2050年までに3,500万人に達すると予測しており、これは2022年に記録された2,000万人から77％増加することを意味します。とはいえ、腫瘍学研究、個別化医療、ヘルスケア・イノベーションへの投資が増加していることは、市場拡大の機会をもたらす可能性があります。さらに、高度な生検システムに伴う高コストが市場成長の妨げになる可能性もあります。

低侵襲生検技術市場-主要洞察

調査アナリストの分析によると、世界市場は予測期間（2025年～2032年）に約10.5%のCAGRで毎年成長すると予測されます。

市場セグメンテーションでは、キットと消耗品が2024年に最大の市場シェアを示すと予測されています。

技術別では、リキッドバイオプシーが2024年の主要技術でした。

循環バイオマーカー区分では、2024年には無細胞DNA（cfDNA）が循環バイオマーカーとしてリードしています。

用途別では、2024年に臨床が主要アプリケーションでした。

エンドユーザーセグメンテーションに基づくと、2024年の主要エンドユーザーは病院と診療所でした。

地域別では、北米が2024年の主要収益源でした。

低侵襲生検市場-セグメンテーション分析：

低侵襲生検技術の世界市場は、提供製品、技術、循環バイオマーカー、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は提供製品によって3つのセグメントに分けられる。検査、キット＆消耗品、機器。キット＆消耗品は、使用頻度が高く、使い捨てが可能であり、無菌で正確な診断手技を保証するために不可欠な機能を備えていることから、市場で主導的な役割を果たしています。このカテゴリーには、生検針、鉗子、注射器、試薬、検体採取容器が含まれ、これらはすべて、細針吸引、コア生検、真空支援生検を含む様々な生検法に不可欠です。病院、診断検査室、外来患者におけるこれらの製品に対する継続的な需要は、市場シェアを大幅に押し上げています。

市場は技術別に4つのセグメントに分類される。リキッドバイオプシー、オプティカルバイオプシー、ブラシバイオプシー、色素性病変アッセイ、その他です。リキッドバイオプシーは、簡単な採血でがん関連バイオマーカーを同定できるため、従来の組織生検よりも安全かつ迅速で、患者中心の検査が可能であり、市場拡大の最前線にあります。この検査は、侵襲的な処置を必要とすることなく、疾患の進行、がんの早期発見、治療効果の評価をリアルタイムでモニタリングすることを容易にします。プレシジョン・メディシンの普及と早期がん診断に対する需要の高まりが、様々な臨床環境におけるリキッドバイオプシーの迅速な成長と受容を後押ししています。

市場は、循環バイオマーカーに基づいて4つのセグメントに分類される。循環腫瘍細胞（CTC）、無細胞DNA（cfDNA）、循環腫瘍DNA（ctDNA）、細胞外小胞、その他。無細胞DNA（cfDNA）は市場成長の主な促進要因です。リキッドバイオプシー分野の中でも、無細胞DNA（cfDNA）は非侵襲的ながん診断とモニタリングに不可欠な機能であるため、市場拡大の最前線にあります。腫瘍から血流中に放出されるDNA断片を分析することにより、cfDNAは遺伝子変異、腫瘍負荷、治療抵抗性の同定を容易にします。外科的介入を必要とせずに腫瘍の動態をリアルタイムで把握できることから、プレシジョン・オンコロジーの基本的要素として確立されています。

市場は用途によって2つのカテゴリーに分類される。臨床と治療です。臨床は市場成長の主要な促進要因です。臨床用途は低侵襲生検技術の市場拡大の最前線であり、標準的な診断や疾患モニタリングにおけるこれらの手技の採用が増加していることに後押しされています。病院、診断研究所、専門クリニックは、特に腫瘍学の分野において、早期発見とオーダーメイドの治療計画のために、リキッドバイオプシー、細針吸引、画像誘導生検などの低侵襲技術を徐々に採用しています。

市場はエンドユーザー別に、病院・診療所、学術・調査機関、外来医療センターの3つに区分されます。病院・診療所は、低侵襲生検技術分野のエンドユーザーの中で市場成長の最前線にあり、その理由は患者数の多さ、高度な診断施設の存在、医療専門家の専門知識にあります。このような環境は、特に腫瘍学において、細針吸引、コアニードル生検、リキッドバイオプシーなどの手技が一般的に実施される、疾患発見のための一次治療ポイントとして機能しています。学術研究機関もまた重要な役割を果たしており、革新的な生検法の開発やバイオマーカーの発見に力を注いでいます。対照的に、外来診療センターでは、外来で、費用対効果が高く、回復が早い低侵襲性の手技を好む傾向が強まっているため、導入が増加しています。

低侵襲生検技術市場-地理的洞察

北米は、主にリキッドバイオプシーの採用増加により市場成長をリードしています。がんの罹患率の上昇に加え、早期かつ正確な診断への強い関心が、リキッド生検の臨床への導入を促進しています。さらに、著名なバイオテクノロジー企業の存在、洗練されたヘルスケア・インフラ、支持的な規制の枠組みが市場成長をさらに後押ししています。人口3億3,000万人を超える米国は、医療提供者、支払者、医療を受ける患者の相互関係を特徴とする、世界でも最も複雑なヘルスケアシステムの恩恵を受けています。欧州は、画像診断とナビゲーション技術の進歩により、市場成長率第2位の地域となっています。

低侵襲生検市場-競合情勢：

低侵襲生検市場の競合環境は、さまざまな既存医療機器メーカー、診断企業、新興バイオベンチャー企業の参入によって特徴づけられます。主要企業は、精度を高め手技リスクを低減するように設計された先進的な画像誘導、ロボット支援、AI統合生検ソリューションを開発しています。特に循環腫瘍DNA（ctDNA）と無細胞DNA（cfDNA）に焦点を当てた非侵襲的リキッドバイオプシー技術に投資し、リアルタイムでのがんモニタリングを可能にしています。さらに、企業はより低侵襲な診断アプローチに対する需要の高まりに対応するため、アジア太平洋地域やラテンアメリカ地域で事業を拡大しています。

目次

第1章 低侵襲生検技術市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 低侵襲生検技術の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 低侵襲生検技術の業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 低侵襲生検技術市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 低侵襲生検技術の市場情勢

  • 低侵襲生検技術市場シェア分析（2024年）
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 低侵襲生検技術市場- 提供製品別

  • 概要
    • セグメントシェア分析（提供製品別）
    • テスト
    • キットと消耗品
    • 機器

第8章 低侵襲生検技術市場- 技術別

  • 概要
    • セグメントシェア分析（技術別）
    • 液体生検
    • 光学的生検
    • ブラシ生検
    • 色素性病変アッセイ
    • その他

第9章 低侵襲生検技術市場- 循環バイオメーカー

  • 概要
    • 循環バイオメーカー別セグメントシェア分析
    • 循環腫瘍細胞（CTC）
    • 細胞遊離DNA（cfDNA）
    • 循環腫瘍DNA（ctDNA）
    • 細胞外小胞
    • その他

第10章 低侵襲生検技術市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 臨床
      • 治療モニタリング
      • 予後と再発のモニタリング
      • 治療の選択
      • その他
    • 治療的
      • 肺がん
      • 乳がん
      • 前立腺がん
      • 大腸がん
      • その他

第11章 低侵襲生検技術市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院と診療所
    • 学術研究機関
    • 外来診療センター

第12章 低侵襲生検技術市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析- 低侵襲生検技術業界

  • 競合ダッシュボード
    • Competitive Benchmarking
    • Competitive Positioning
  • 企業プロファイル
    • Becton, Dickinson and Company（BD）
    • Danaher Corporation（Leica Biosystems）
    • Hologic, Inc.
    • Boston Scientific Corporation
    • Medtronic plc
    • Siemens Healthineers
    • GE HealthCare
    • Philips Healthcare
    • Argon Medical Devices
    • Cook Medical
    • Fujifilm Holdings Corporation
    • Olympus Corporation
    • R. Bard（now part of BD）
    • Biocept, Inc.
    • Guardant Health
    • Qiagen NV
    • Exact Sciences Corporation
    • Bio-Rad Laboratories
    • Menarini Silicon Biosystems
    • NeoGenomics Laboratories
    • Others

第14章 アナリストの全方位展望

目次
Product Code: ANV5422

REPORT HIGHLIGHT

Minimally Invasive Biopsy Techniques Market size was valued at US$ 13,146.12 Million in 2024, expanding at a CAGR of 10.5% from 2025 to 2032.

Minimally invasive biopsy techniques refer to procedures that obtain tissue samples for diagnostic purposes through smaller incisions and with less damage to surrounding tissue than traditional surgical biopsies. These methods present benefits such as diminished scarring, quicker recovery times, and a lower likelihood of complications. Frequently utilized techniques include fine-needle aspiration (FNA), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB), which are often performed with the assistance of imaging technologies such as ultrasound, MRI, or mammography. Overall, minimally invasive biopsy techniques represent a significant advancement in tissue sampling, delivering precise diagnoses while minimizing the burden on patients.

Minimally Invasive Biopsy Techniques Market- Market Dynamics

The increasing global prevalence of cancer, along with the growing significance of precision diagnostics, is anticipated to propel market growth.

As the incidence of cancer continues to rise globally, there is an urgent requirement for early, precise, and less invasive diagnostic methods. Minimally invasive biopsy techniques, including fine-needle aspiration, core needle biopsy, and liquid biopsy, provide quicker recovery times, decreased patient discomfort, and lower rates of complications when compared to conventional surgical approaches. The World Health Organization estimates that the number of new cancer cases is expected to reach 35 million by 2050, which signifies a 77% increase from the 20 million cases documented in 2022. Nevertheless, increasing investments in oncology research, personalized medicine, and healthcare innovation may present opportunities for market expansion. Furthermore, the high costs associated with advanced biopsy systems could hinder market growth.

Minimally Invasive Biopsy Techniques Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.5% over the forecast period (2025-2032)

Based on Product Offered segmentation, Kits & Consumables were predicted to show the maximum market share in the year 2024

Based on Technique segmentation, Liquid Biopsy was the leading Technique in 2024

Based on Circulating Biomarker segmentation, cell-free DNA (cfDNA) was the leading Circulating Biomarker in 2024

Based on Application segmentation, Clinical was the leading Application in 2024

Based on end-user segmentation, Hospitals and clinics were the leading end users in 2024

Based on region, North America was the leading revenue generator in 2024

Minimally Invasive Biopsy Techniques Market- Segmentation Analysis:

The Global Minimally Invasive Biopsy Techniques Market is segmented based on Product Offered, Technique, Circulating Biomarker, Application, End User, and Region.

The market is divided into three segments according to the Products Offered: Tests, Kits & Consumables, and Instruments. Kits & Consumables occupy a leading role in the market, attributed to their frequent usage, disposability, and essential function in ensuring sterile and accurate diagnostic procedures. This category encompasses biopsy needles, forceps, syringes, reagents, and sample collection containers, all of which are vital for various biopsy methods, including fine-needle aspiration, core needle biopsy, and vacuum-assisted biopsy. The ongoing demand for these products in hospitals, diagnostic laboratories, and outpatient settings significantly boosts their substantial market share.

The market is categorized into four segments based on Technique: Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, and Others. Liquid Biopsy is at the forefront of market expansion, owing to its capability to identify cancer-related biomarkers through a straightforward blood draw, providing a safer, quicker, and more patient-centric alternative to conventional tissue biopsies. It facilitates real-time monitoring of disease progression, early cancer detection, and evaluation of treatment responses without requiring invasive procedures. The growing adoption of precision medicine and the increasing demand for early cancer diagnostics are propelling the swift growth and acceptance of liquid biopsy in various clinical environments.

The market is categorized into four segments based on circulating Biomarkers: Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, and Others. Cell-Free DNA (cfDNA) is the primary driver of market growth. Within the liquid biopsy sector, cell-free DNA (cfDNA) is at the forefront of market expansion due to its essential function in non-invasive cancer diagnostics and monitoring. By analyzing fragments of DNA released by tumors into the bloodstream, cfDNA facilitates the identification of genetic mutations, tumor burden, and treatment resistance. Its capacity to deliver real-time insights into tumor dynamics without requiring surgical interventions has established it as a fundamental element in precision oncology.

The market is segmented into two categories according to Application: Clinical and Therapeutic. Clinical is the primary driver of market growth. Clinical applications are at the forefront of market expansion in minimally invasive biopsy techniques, propelled by the rising adoption of these procedures in standard diagnostics and disease monitoring. Hospitals, diagnostic laboratories, and specialty clinics are progressively employing minimally invasive techniques such as liquid biopsy, fine-needle aspiration, and image-guided biopsies for early detection and tailored treatment planning, especially in the field of oncology.

The market is segmented into three categories based on End-User: Hospitals & Clinics, Academic & Research Institutions, and Ambulatory Care Centers. Hospitals and clinics are at the forefront of market growth among end users in the minimally invasive biopsy techniques sector, attributed to the high patient volume, the presence of advanced diagnostic facilities, and the expertise of medical professionals. These environments serve as the primary point of care for disease detection, particularly in oncology, where procedures such as fine-needle aspiration, core needle biopsy, and liquid biopsy are commonly conducted. Academic and research institutions also play a vital role, concentrating on the advancement of innovative biopsy methods and the discovery of biomarkers. In contrast, ambulatory care centers are witnessing an increase in adoption due to the growing preference for outpatient, cost-effective, and minimally invasive procedures that offer faster recovery times.

Minimally Invasive Biopsy Techniques Market- Geographical Insights

North America leads in market growth, primarily due to the increasing adoption of liquid biopsy. The rising incidence of cancer, along with a strong focus on early and accurate diagnosis, has expedited the incorporation of liquid biopsy into clinical practices. Furthermore, the presence of prominent biotechnology firms, sophisticated healthcare infrastructure, and supportive regulatory frameworks has further propelled market growth. The United States (US), with a population exceeding 330 million, benefits from one of the most intricate healthcare systems globally, characterized by the interconnected relationships among providers, payers, and patients receiving care. Europe ranks as the second largest region for market growth, attributed to advancements in imaging and navigation technologies.

Minimally Invasive Biopsy Techniques Market- Competitive Landscape:

The competitive environment of the Minimally Invasive Biopsy Techniques Market is characterized by the participation of various established medical device manufacturers, diagnostic firms, and emerging biotech startups. Leading companies are developing advanced imaging-guided, robotic-assisted, and AI-integrated biopsy solutions designed to enhance accuracy and reduce procedural risks. Organizations are investing in non-invasive liquid biopsy technologies, especially those focusing on circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA), to enable real-time cancer monitoring. Furthermore, companies are broadening their operations in the Asia-Pacific and Latin America regions to take advantage of the growing demand for less invasive diagnostic approaches.

Recent Developments:

On January 22, 2025, GRACE Breast Imaging & Medical Spa of Iowa, located in Urbandale and Clive, achieved a significant milestone by becoming the first healthcare facility in the United States to install the innovative Mammomat B.brilliant. This marks the first complete redesign of a mammography platform by Siemens Healthineers in over ten years. The Mammomat B.brilliant incorporates advanced 3D image acquisition and image reconstruction technology, along with capabilities for full-field digital mammography, which includes two-dimensional breast imaging, breast biopsy, and titanium contrast-enhanced mammography.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Becton, Dickinson and Company (BD)
  • Danaher Corporation (Leica Biosystems)
  • Hologic, Inc.
  • Boston Scientific Corporation
  • Medtronic plc
  • Siemens Healthineers
  • GE HealthCare
  • Philips Healthcare
  • Argon Medical Devices
  • Cook Medical
  • Fujifilm Holdings Corporation
  • Olympus Corporation
  • R. Bard (now part of BD)
  • Biocept, Inc.
  • Guardant Health
  • Qiagen N.V.
  • Exact Sciences Corporation
  • Bio-Rad Laboratories
  • Menarini Silicon Biosystems
  • NeoGenomics Laboratories
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY PRODUCT OFFERED- MARKET ANALYSIS, 2019 - 2032

  • Tests
  • Kits & Consumables
  • Instruments

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

  • Liquid Biopsy
  • Optical Biopsy
  • Brush Biopsy
  • Pigmented Lesion Assays
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY CIRCULATING BIOMAKER- MARKET ANALYSIS, 2019 - 2032

  • Circulating Tumor Cells (CTCs)
  • Cell Free DNA (cfDNA)
  • Circulating Tumor DNA (ctDNA)
  • Extracellular Vesicles
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical
  • Treatment Monitoring
  • Prognosis & Recurrence Monitoring
  • Treatment Selection
  • Others
  • Therapeutic
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Ambulatory Care Centers

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Minimally Invasive Biopsy Techniques Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Minimally Invasive Biopsy Techniques Market Snippet by Product Offered
    • 2.1.2. Minimally Invasive Biopsy Techniques Market Snippet by Technique
    • 2.1.3. Minimally Invasive Biopsy Techniques Market Snippet by Circulating Biomaker
    • 2.1.4. Minimally Invasive Biopsy Techniques Market Snippet by Application
    • 2.1.5. Minimally Invasive Biopsy Techniques Market Snippet by End User
    • 2.1.6. Minimally Invasive Biopsy Techniques Market Snippet by Country
    • 2.1.7. Minimally Invasive Biopsy Techniques Market Snippet by Region
  • 2.2. Competitive Insights

3. Minimally Invasive Biopsy Techniques Key Market Trends

  • 3.1. Minimally Invasive Biopsy Techniques Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Minimally Invasive Biopsy Techniques Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Minimally Invasive Biopsy Techniques Market Opportunities
  • 3.4. Minimally Invasive Biopsy Techniques Market Future Trends

4. Minimally Invasive Biopsy Techniques Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Minimally Invasive Biopsy Techniques Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Minimally Invasive Biopsy Techniques Market Landscape

  • 6.1. Minimally Invasive Biopsy Techniques Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Minimally Invasive Biopsy Techniques Market - By Product Offered

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Offered, 2024 & 2032 (%)
    • 7.1.2. Tests
    • 7.1.3. Kits & Consumables
    • 7.1.4. Instruments

8. Minimally Invasive Biopsy Techniques Market - By Technique

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technique, 2024 & 2032 (%)
    • 8.1.2. Liquid Biopsy
    • 8.1.3. Optical Biopsy
    • 8.1.4. Brush Biopsy
    • 8.1.5. Pigmented Lesion Assays
    • 8.1.6. Others

9. Minimally Invasive Biopsy Techniques Market - By Circulating Biomaker

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Circulating Biomaker, 2024 & 2032 (%)
    • 9.1.2. Circulating Tumor Cells (CTCs)
    • 9.1.3. Cell Free DNA (cfDNA)
    • 9.1.4. Circulating Tumor DNA (ctDNA)
    • 9.1.5. Extracellular Vesicles
    • 9.1.6. Others

10. Minimally Invasive Biopsy Techniques Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Clinical
      • 10.1.2.1. Treatment Monitoring
      • 10.1.2.2. Prognosis & Recurrence Monitoring
      • 10.1.2.3. Treatment Selection
      • 10.1.2.4. Others
    • 10.1.3. Therapeutic
      • 10.1.3.1. Lung Cancer
      • 10.1.3.2. Breast Cancer
      • 10.1.3.3. Prostate Cancer
      • 10.1.3.4. Colorectal Cancer
      • 10.1.3.5. Others

11. Minimally Invasive Biopsy Techniques Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals & Clinics
    • 11.1.3. Academic & Research Institutions
    • 11.1.4. Ambulatory Care Centers

12. Minimally Invasive Biopsy Techniques Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Minimally Invasive Biopsy Techniques Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Minimally Invasive Biopsy Techniques Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Becton, Dickinson and Company (BD)
    • 13.2.2. Danaher Corporation (Leica Biosystems)
    • 13.2.3. Hologic, Inc.
    • 13.2.4. Boston Scientific Corporation
    • 13.2.5. Medtronic plc
    • 13.2.6. Siemens Healthineers
    • 13.2.7. GE HealthCare
    • 13.2.8. Philips Healthcare
    • 13.2.9. Argon Medical Devices
    • 13.2.10. Cook Medical
    • 13.2.11. Fujifilm Holdings Corporation
    • 13.2.12. Olympus Corporation
    • 13.2.13. R. Bard (now part of BD)
    • 13.2.14. Biocept, Inc.
    • 13.2.15. Guardant Health
    • 13.2.16. Qiagen N.V.
    • 13.2.17. Exact Sciences Corporation
    • 13.2.18. Bio-Rad Laboratories
    • 13.2.19. Menarini Silicon Biosystems
    • 13.2.20. NeoGenomics Laboratories
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us